Results 101 to 110 of about 12,381 (205)
Radioimmunotherapy for Colorectal Cancer [PDF]
Clinical Cancer Research, 2005 Monoclonal antibodies, selected for their ability to recognize and bind tumor-specific antigens, are a promising vehicle for systemic antitumor therapy. Radioimmunotherapy utilizes radioisotopes conjugated to monoclonal antibodies to deliver tumoricidal radiation doses.
openaire +2 more sources
Adaptive immunity in cancer immunology and therapeutics. [PDF]
, 2014 Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
Lockley, M, Spurrell, EL
core +2 more sources
Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database [PDF]
, 2013 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/100290/1/bjh12570 ...
Abel, Gregory A. +14 more
core +1 more source
Pharmaceuticals, 2019 The development of monoclonal antibodies has dramatically changed the outcome of patients with non-Hodgkin’s lymphoma (NHL), the most common hematological malignancy.
Christos Sachpekidis +2 more
doaj +1 more source
Radioimmunotherapy: a brief overview
Biomedical Imaging and Intervention Journal, 2006 With the advent of biotechnological advances and knowledge of molecular and cellular biology, radioimmunotherapy (RIT) has become a highly promising oncologic therapeutic modality with established clinically efficacy, particularly in non-Hodgkin's lymphomas.
openaire +2 more sources
The effect of temperature on the bystander effect as examined in human prostate carcinoma cells with alpha particle irradiation [PDF]
, 2006 Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2006."June 2006."Includes bibliographical references (p. 30-32).The bystander effect is seen when irradiated cells release a factor that can produce damage or
Sheppard, Sarah (Sarah Elizabeth)
core
Experimental and clinical approaches to a radioimmunotherapy in o
Сибирский онкологический журнал, 2016 Molecular nuclear medicine plays an important role in the diagnosis and therapy of cancer. Radioimmunodetection and radioimmunotherapy (RIT) involve the use of antibodies conjugated with diagnostic or therapeutic radionuclides, respectively.
E. V. Abakushina +2 more
doaj
177Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model
AntibodiesThis study investigated a novel radioimmunotherapy strategy for targeting tumor angiogenesis. We developed a radiopharmaceutical complex by labeling an anti-adenosine triphosphate synthase (ATPS) monoclonal antibody (mAb) with the radioisotope 177Lu ...
Bok-Nam Park +5 more
doaj +1 more source
CNS Oncology, 2019 Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting ...
Joshua Loya +4 more
doaj +1 more source
Cancer immunotherapy: current progress and applications [PDF]
, 2006 Cancer immunotherapy is a form of treatment protocol for cancer patients that have been studied intensively over the last two decades. The undesirable side effects during the course of conventional treatment have lead to the development of immunotherapy ...
Leong, Pooi Pooi, Seow, Heng Fong
core